Adherence to Long-Term Therapies - Evidence for Action
(2003; 211 pages) View the PDF document
Table of Contents
View the documentPreface
View the documentAcknowledgements
View the documentScientific writers
View the documentIntroduction
View the documentTake-home messages
Open this folder and view contentsSection I - Setting the scene
Open this folder and view contentsSection II - Improving adherence rates: guidance for countries
Close this folderSection III - Disease-Specific Reviews
Close this folderChapter VII - Asthma
View the document1. Defining nonadherence to asthma therapy
View the document2. Rates of adherence to inhaled corticosteroids and other drugs for the prevention of asthma
View the document3. Forms of nonadherence
View the document4. Factors associated with adherence to asthma treatment
View the document5. Adherence in special populations
View the document6. Interventions to improve adherence to asthma therapy
View the document7. Discussion
View the document8. Conclusions
View the document9. References
Open this folder and view contentsChapter VIII - Cancer (Palliative care)
Open this folder and view contentsChapter IX - Depression
Open this folder and view contentsChapter X - Diabetes
Open this folder and view contentsChapter XI - Epilepsy
Open this folder and view contentsChapter XII - Human immunodeficiency virus and acquired immunodeficiency syndrome
Open this folder and view contentsChapter XIII - Hypertension
Open this folder and view contentsChapter XIV - Tobacco smoking cessation
Open this folder and view contentsChapter XV - Tuberculosis
Open this folder and view contentsAnnexes
Open this folder and view contentsWhere to find a copy of this book
 

Chapter VII - Asthma

Asthma is a chronic, inflammatory disease of the airways that has dramatically increased in incidence over the past 15 years in both developed and developing countries. The global burden of asthma is considerable. Its effects include reduced quality of life, lost productivity, missed school days, increased health care costs, the risk of hospitalization and even death (1).

Although effective treatments that have been shown to dramatically reduce asthma morbidity are available, they are effective only when properly used by patients. Because human behaviour is the necessary interface between good therapies and therapeutic effectiveness, both clinical researchers and clinicians should understand the factors associated with patient adherence. This chapter discusses adherence issues in asthma, with a particular focus on adherence to preventive therapy, such as inhaled corticosteroids (ICSs).The prevalence of nonadherence to preventive therapy and patient factors associated with nonadherence are reviewed. Finally, we suggest some directions for future field research.

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: October 7, 2014